63
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Norwegian men diagnosed with genital Chlamydia trachomatis infection notified two-thirds of their sexual partners

, &
Pages 275-278 | Received 05 Jun 2007, Published online: 08 Jul 2009
 

Abstract

Chlamydia trachomatis (CT) is a widespread, sexually transmitted disease with potential long-term effects on female reproductive health. The objective of this study was to investigate compliance to treatment, partner notification, and attendance for test-of-cure among Norwegian men diagnosed with CT. We conducted a longitudinal case-series study among 81 CT positive men identified in a cross-sectional study (n=1032, April–December 2005). Participants were interviewed on partner notification intentions at the treatment visit and on partner notification actions at the test-of-cure visit. Of the 81 patients, 8 (10%) did not meet for treatment, 2 were treated elsewhere, and 6 were treated but not interviewed. At the treatment visit, the 65 interviewed men reported that they intended to notify 100 out of 165 partners (61%). 40 of 71 treated patients attended for test-of-cure (56%). Four men (10%) needed repeated treatment. The 35 men interviewed at test-of-cure visit reported that 63 out of 95 partners (68%) had been notified. In conclusion, men diagnosed with CT infection are relatively open on notifying sexual partners but have low compliance to meeting for test-of-cure.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.